Drawing for OR2PACK

USPTO serial 79285754

OR2PACK

Reviewed by CopyMark Law Group

Reg. 6258772Status 700Renewal
Filing date
Status date
Registration date
Feb 2, 2021
Examiner
MACIOL II, EUGENE VALENTINE-JO
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OR2PACK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Janet G Ricciuti

Janet G Ricciuti JANET GILBERT RICCIUTI1830 S STREET NWWASHINGTON, DC 20009UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Packaging solution for pharmaceutical use, namely, drug delivery agents embedded in matrixes that provide controlled release of the active ingredients for a wide variety of pharmaceuticals, the above-mentioned product not in connection with the region of the earACTIVE—
010Surgical apparatus and instruments; protections for medical instruments, namely, carrying cases specially adapted for holding or carrying medical implants; medical device packaging solution, namely, carrying cases specially adapted for medical implants, the above-mentioned products not in connection with the region of the earACTIVE—
042Analysis and evaluation of product design; analysis and evaluation of product development; packaging design services; prosthesis design services; pharmaceutical product development; industrial product development; development of packaging for pharmaceutical and surgical use; testing of new pharmaceutical and surgical products of others; research and development of new products; pharmaceutical research and development; research and development for the pharmaceutical industry; engineering service; the above-mentioned services not in connection with the region of the earACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 2, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 30, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 7, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 7, 2021FIMPFINAL DISPOSITION PROCESSED—
May 2, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 2, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 17, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 17, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 28, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 13, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 24, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Sep 24, 2020ALIEASSIGNED TO LIE—
Sep 24, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 24, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 24, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 21, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 21, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 21, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 2, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 1, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 1, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2020RFNTREFUSAL PROCESSED BY IB—
Jul 2, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 2, 2020RFRRREFUSAL PROCESSED BY MPU—
Jun 2, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 1, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
May 22, 2020DOCKASSIGNED TO EXAMINER—
May 22, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 21, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance